| Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma L De Mattos-Arruda, R Mayor, CKY Ng, B Weigelt, F Martínez-Ricarte, ... Nature communications 6 (1), 8839, 2015 | 739 | 2015 |
| Genomic characterization of metastatic breast cancers F Bertucci, CKY Ng, A Patsouris, N Droin, S Piscuoglio, N Carbuccia, ... Nature 569 (7757), 560-564, 2019 | 549 | 2019 |
| Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients L Quagliata, MS Matter, S Piscuoglio, L Arabi, C Ruiz, A Procino, M Kovac, ... Hepatology 59 (3), 911-923, 2014 | 441 | 2014 |
| Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle L De Mattos-Arruda, B Weigelt, J Cortes, HH Won, CKY Ng, P Nuciforo, ... Annals of oncology 25 (9), 1729-1735, 2014 | 393 | 2014 |
| Breast cancer intra-tumor heterogeneity LG Martelotto, CKY Ng, S Piscuoglio, B Weigelt, JS Reis-Filho Breast Cancer Research 16, 1-11, 2014 | 367 | 2014 |
| Organoid models of human liver cancers derived from tumor needle biopsies S Nuciforo, I Fofana, MS Matter, T Blumer, D Calabrese, T Boldanova, ... Cell reports 24 (5), 1363-1376, 2018 | 357 | 2018 |
| Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer E Donnarumma, D Fiore, M Nappa, G Roscigno, A Adamo, M Iaboni, ... Oncotarget 8 (12), 19592, 2017 | 300 | 2017 |
| Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer B Weigelt, I Comino-Méndez, I de Bruijn, L Tian, JL Meisel, ... Clinical Cancer Research 23 (21), 6708-6720, 2017 | 236 | 2017 |
| YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis R Gao, RKR Kalathur, M Coto‐Llerena, C Ercan, D Buechel, S Shuang, ... EMBO molecular medicine 13 (12), e14351, 2021 | 235 | 2021 |
| Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ... Nature genetics 46 (11), 1166-1169, 2014 | 221 | 2014 |
| The protein histidine phosphatase LHPP is a tumour suppressor SK Hindupur, M Colombi, SR Fuhs, MS Matter, Y Guri, K Adam, M Cornu, ... Nature 555 (7698), 678-682, 2018 | 181 | 2018 |
| Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas AM Schultheis, CKY Ng, MR De Filippo, S Piscuoglio, GS Macedo, ... Journal of the National Cancer Institute 108 (6), djv427, 2016 | 179 | 2016 |
| The genomic landscape of male breast cancers S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ... Clinical Cancer Research 22 (16), 4045-4056, 2016 | 151 | 2016 |
| Genomic landscape of adenoid cystic carcinoma of the breast LG Martelotto, MR De Filippo, CKY Ng, R Natrajan, L Fuhrmann, J Cyrta, ... The Journal of pathology 237 (2), 179-189, 2015 | 151 | 2015 |
| Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification CKY Ng, LG Martelotto, A Gauthier, HC Wen, S Piscuoglio, RS Lim, ... Genome biology 16, 1-21, 2015 | 150 | 2015 |
| The landscape of somatic genetic alterations in metaplastic breast carcinomas CKY Ng, S Piscuoglio, FC Geyer, KA Burke, F Pareja, CA Eberle, RS Lim, ... Clinical cancer research 23 (14), 3859-3870, 2017 | 144 | 2017 |
| Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations LG Martelotto, CKY Ng, MR De Filippo, Y Zhang, S Piscuoglio, RS Lim, ... Genome biology 15, 1-20, 2014 | 141 | 2014 |
| Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples LG Martelotto, T Baslan, J Kendall, FC Geyer, KA Burke, L Spraggon, ... Nature medicine 23 (3), 376-385, 2017 | 135 | 2017 |
| Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ... Nature communications 9 (1), 1816, 2018 | 132 | 2018 |
| Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene … S Piscuoglio, CKY Ng, M Murray, KA Burke, M Edelweiss, FC Geyer, ... The Journal of pathology 238 (4), 508-518, 2016 | 122 | 2016 |
Charlotte K Y NgHumanitas University and University of BernVerified email at unibe.ch
